(Q37764342)

22 August 2017

1 reference

title

DHEA therapy in postmenopausal women: the need to move forward beyond the lack of evidence (English)

1 reference

22 August 2017

A R Genazzani

1

1 reference

22 August 2017

N Pluchino

series ordinal

2

1 reference

22 August 2017

publication date

1 August 2010

1 reference

22 August 2017

1 reference

22 August 2017

volume

13

1 reference

22 August 2017

issue

4

1 reference

22 August 2017

page(s)

314-316

1 reference

Is dehydroepiandrosterone a hormone?

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.492496

Circulating androgen levels and self-reported sexual function in women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.492496

Dehydroepiandrosterone sulfate levels are associated with more favorable cognitive function in women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.492496

Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.492496

Dehydroepiandrosterone modulates endothelial nitric oxide synthesis via direct genomic and nongenomic mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.492496

Serum steroid levels during 12-week intravaginal dehydroepiandrosterone administration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.492496

One-year therapy with 10mg/day DHEA alone or in combination with HRT in postmenopausal women: effects on hormonal milieu

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.492496

10.3109/13697137.2010.492496

21 January 2018

Identifiers

DOI

1 reference

22 August 2017

1 reference